Terms: = Ovarian cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1 AND Prognosis
27 results:
1. [Gonadoblastoma: Clinicopathological study and literature review of 3 cases].
Bao ML; Li X; Chen G; Li H; Chen W; Li HX
Zhonghua Nan Ke Xue; 2023 Jul; 29(7):634-638. PubMed ID: 38619412
[TBL] [Abstract] [Full Text] [Related]
2. Review on Sertoli-Leydig Cell Tumours of the Ovary.
Muscat C; Calleja-Agius J
Discov Med; 2024 Feb; 36(181):234-247. PubMed ID: 38409829
[TBL] [Abstract] [Full Text] [Related]
3. Pediatric Sertoli-Leydig Cell Tumors of the Ovary: An Integrated Study of Clinicopathological Features, Pan-cancer-Targeted Next-generation Sequencing and Chromosomal Microarray Analysis From a Single Institution.
Yang B; Chour W; Salazar CG; Zamiara P; Schmidt RJ; Raca G; Shillingford N; Zhou S; Warren M; Parham DM; Pawel B; Wang LL
Am J Surg Pathol; 2024 Feb; 48(2):194-203. PubMed ID: 37946548
[TBL] [Abstract] [Full Text] [Related]
4. Immunohistochemical markers of prognosis in adult granulosa cell tumors of the ovary - a review.
Jung D; Almstedt K; Battista MJ; Seeger A; Jäkel J; Brenner W; Hasenburg A
J Ovarian Res; 2023 Mar; 16(1):50. PubMed ID: 36869369
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic significance of tumor budding, poorly differentiated cluster, and desmoplastic reaction in endometrioid endometrial carcinomas.
Yamamoto M; Kaizaki Y; Kogami A; Hara T; Sakai Y; Tsuchida T
J Obstet Gynaecol Res; 2021 Nov; 47(11):3958-3967. PubMed ID: 34448279
[TBL] [Abstract] [Full Text] [Related]
6. Juvenile Granulosa Cell Tumors of the Ovary.
Ye Y; Lv C; Xu S; Chen Y; Qian R; Wang P; Wang S
Am J Clin Pathol; 2020 Oct; 154(5):635-644. PubMed ID: 32561911
[TBL] [Abstract] [Full Text] [Related]
7. Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.
Da Cruz Paula A; da Silva EM; Segura SE; Pareja F; Bi R; Selenica P; Kim SH; Ferrando L; Vahdatinia M; Soslow RA; Vidal A; Gatius S; Przybycin CG; Abu-Rustum NR; Matias-Guiu X; Rubin BP; Reis-Filho JS; DeLair DF; Weigelt B
Mod Pathol; 2020 Aug; 33(8):1606-1617. PubMed ID: 32203090
[TBL] [Abstract] [Full Text] [Related]
8. Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma.
Sallinen H; Janhonen S; Pölönen P; Niskanen H; Liu OH; Kivelä A; Hartikainen JM; Anttila M; Heinäniemi M; Ylä-Herttuala S; Kaikkonen MU
BMC Cancer; 2019 Nov; 19(1):1121. PubMed ID: 31744494
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma.
Yoshida K; Yoshikawa N; Shirakawa A; Niimi K; Suzuki S; Kajiyama H; Kikkawa F
J Gynecol Oncol; 2019 Nov; 30(6):e85. PubMed ID: 31576683
[TBL] [Abstract] [Full Text] [Related]
10. Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods.
Paik ES; Lee JW; Park JY; Kim JH; Kim M; Kim TJ; Choi CH; Kim BG; Bae DS; Seo SW
J Gynecol Oncol; 2019 Jul; 30(4):e65. PubMed ID: 31074247
[TBL] [Abstract] [Full Text] [Related]
11. Identification of Candidate Genes Associated with Chemotherapy Resistance in ovarian cancer.
Zhang B; Wang L; Zhao X; Wei Y; Zhang Y
Ann Clin Lab Sci; 2018 Sep; 48(5):573-579. PubMed ID: 30373860
[TBL] [Abstract] [Full Text] [Related]
12. Detection of the DICER1 hotspot mutation alongside immunohistochemical analysis may provide a better diagnostic measure for ovarian Sertoli-Leydig cell tumors.
Zhang X; Shen D; Wang Y
Pathol Res Pract; 2018 Sep; 214(9):1370-1375. PubMed ID: 30072170
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA profiling of ovarian granulosa cell tumours reveals novel diagnostic and prognostic markers.
Cheng WT; Rosario R; Muthukaruppan A; Wilson MK; Payne K; Fong PC; Shelling AN; Blenkiron C
Clin Epigenetics; 2017; 9():72. PubMed ID: 28736583
[TBL] [Abstract] [Full Text] [Related]
14. Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G foxl2 mutation.
Yanagida S; Anglesio MS; Nazeran TM; Lum A; Inoue M; Iida Y; Takano H; Nikaido T; Okamoto A; Huntsman DG
PLoS One; 2017; 12(6):e0178989. PubMed ID: 28594898
[TBL] [Abstract] [Full Text] [Related]
15. foxl2 Mutation Status in Granulosa Theca Cell Tumors of the Ovary.
Nolan A; Joseph NM; Sangoi AR; Rabban J; Zaloudek C; Garg K
Int J Gynecol Pathol; 2017 Nov; 36(6):568-574. PubMed ID: 28319575
[TBL] [Abstract] [Full Text] [Related]
16. Pathogenesis and treatment of adult-type granulosa cell tumor of the ovary.
Färkkilä A; Haltia UM; Tapper J; McConechy MK; Huntsman DG; Heikinheimo M
Ann Med; 2017 Aug; 49(5):435-447. PubMed ID: 28276867
[TBL] [Abstract] [Full Text] [Related]
17. Genetics and genomics of ovarian sex cord-stromal tumors.
Fuller PJ; Leung D; Chu S
Clin Genet; 2017 Feb; 91(2):285-291. PubMed ID: 27813081
[TBL] [Abstract] [Full Text] [Related]
18. Characteristics and outcome of recurrence in molecularly defined adult-type ovarian granulosa cell tumors.
Bryk S; Färkkilä A; Bützow R; Leminen A; Tapper J; Heikinheimo M; Unkila-Kallio L; Riska A
Gynecol Oncol; 2016 Dec; 143(3):571-577. PubMed ID: 27729108
[TBL] [Abstract] [Full Text] [Related]
19. DICER1 and foxl2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
[TBL] [Abstract] [Full Text] [Related]
20. Stage I granulosa cell tumours: A management conundrum? Results of long-term follow up.
Wilson MK; Fong P; Mesnage S; Chrystal K; Shelling A; Payne K; Mackay H; Wang L; Laframboise S; Rouzbahman M; Levin W; Oza AM
Gynecol Oncol; 2015 Aug; 138(2):285-91. PubMed ID: 26003143
[TBL] [Abstract] [Full Text] [Related]
[Next]